Hyoung Kim, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8775 Norwin Ave Ste J, Suite 102, North Huntingdon, PA 15642 Phone: 724-834-1463 |
Navkiranjit Gill, Internal Medicine - Medical Oncology Medicare: Accepting Medicare Assignments Practice Location: 8775 Norwin Ave Ste J, Suite J Excela Square, North Huntingdon, PA 15642 Phone: 724-834-1463 |
Ralph A. Capone, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12120 State Route 30, Suite 40, North Huntingdon, PA 15642 Phone: 724-863-4362 |
Dr. Michelle A Rathgeb, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8775 Norwin Ave, North Huntingdon, PA 15642 Phone: 724-864-8491 Fax: 724-864-8496 |
News Archive
Scientists working to develop new treatments for neurodegenerative diseases have been stymied by the inability to grow human motor neurons in the lab. Motor neurons drive muscle contractions, and their damage underlies devastating diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy, both of which ultimately lead to paralysis and early death.
Although children are more likely than adults to suffer from many diseases, few clinical trials are being conducted to test drugs in pediatric patients, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies (PAS) annual meeting in Boston.
Governor Tim Pawlenty's budget proposal announced today will severely hurt Minnesota's hospitals and the citizens they serve. His proposed budget would reduce payment rates for patients in state health programs, cut spending on medical education and put adults without children now covered by MinnesotaCare into the growing ranks of the uninsured. The current budget proposal would only make things worse in both the short term and the long term. If the governor's budget is adopted, hospitals will more than likely need to layoff more skilled workers and cut much-needed services.
Researchers at the Institute of Biomedical Research of Bellvitge, led by Dr. Eva Gonzalez-Suarez, have shown that pharmacological and genetic inhibition of signaling pathway RANK / RANKL leads to a significant reduction in recurrences and metastases in breast cancer in a mouse animal model.
› Verified 2 days ago